Serum RAC1 as a potential biomarker in the early stages of diabetic kidney disease
Yao Fang, Xianyang Mo, Nan Wang, Qunwei Ma, Ruirui Fu, Ying Sun, Tingting Yang, Jaishi Bishnu Raj, Xiaoyan Zhou, Changjiang Ying · 2025
Read Serum RAC1 as a potential biomarker in the early stages of diabetic kidney disease by Yao Fang, Xianyang Mo, Nan Wang, Qunwei Ma, Ruirui Fu, Ying Sun, Tingting Yang, Jaishi Bishnu Raj, Xiaoyan Zhou, Changjiang Ying (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12709860.txt.
Description
Yao Fang and co-authors test a blood protein as an early warning sign of diabetic kidney disease in a 2025 study. The protein, called RAC1, speeds kidney damage in lab models by driving inflammation and scarring, but its value in patients was unknown.
One hundred fifty people took part: healthy volunteers, patients with type two diabetes, and patients with early kidney disease. Blood levels of the protein were highest in the early disease group. They rose with urine markers of kidney strain and fell as kidney function estimates rose. Levels also moved together with inflammation and scarring markers. Even after adjusting for those, higher levels still meant higher odds of early disease.
Catalog record
| CREATOR | Yao Fang, Xianyang Mo, Nan Wang, Qunwei Ma, Ruirui Fu, Ying Sun, Tingting Yang, Jaishi Bishnu Raj, Xiaoyan Zhou, Changjiang Ying |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |